当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第23期
编号:13413316
血清对氧磷酶-1研究进展(4)
http://www.100md.com 2019年8月15日 《中国医药导报》 2019年第23期
     [20] Li XQ,Ma N,Li XG,et al. Association of PON1,P2Y12 and COX1 with recurrent ischemic events in patients with extracranial or intracranial stenting [J]. PLoS One,2016,11(2):e0148891.

    [21] Kotur-Stevuljevic J,Bogavac-Stanojevic N,Jelic-Ivanovic Z,et al. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients [J]. Atherosclerosis,2015, 241(1):192-198.

    [22] Wu J,Fang M,Zhou X,et al. Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women [J]. Oncotarget,2017,8(15):25362-25371.

    [23] Mustafa OK,Sinan S,Ozen OG,et al. Is there a relation between genetic susceptibility with cancer? a study about paraoxanase (PON1) enzyme activity in breast cancer cases [J]. J Enzyme Inhib Med Chem,2016,31(6):1349-1355.

    [24] Arenas M,Garcia-Heredia A,CabreN,et al. Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients [J]. PLoS One,2017, 12(11):e0188633.

    [25] Mbd A,Son YS,Sung HJ,et al. Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells [J]. Oncotarget,2017,8(26):42817-42835.

    [26] Dowling P,Hayes C,Ting K,et al. Identification of proteins found to be significantly altered when comparing the serum proteome from multiple myeloma patients with varying degrees of bone disease [J]. BMC Genomics,2014, 15(1):904.

    (收稿日期:2019-02-19 本文編辑:李亚聪), 百拇医药(赫兰 唐伟 于勤)
上一页1 2 3 4